STAT+: A Sellas immunotherapy study, long delayed, will end in failure

Written and edited by the WorldPing NewsdeskPublished Updated Original reporting: STAT
STAT+: A Sellas immunotherapy study, long delayed, will end in failureWorldPing
Image via STAT.

What happened

Why Sellas' experimental immunotherapy study is a blowup waiting to happen.

Key facts

  • Reported by STAT and published Thu, 17 Sep 2026 10:30:00 UTC.

Why it matters

Outbreaks, approvals and guidance changes have direct practical consequences for care, travel and public-health planning.

What to watch next

  • Case numbers and official guidance updates
  • Regulatory decisions in other countries
  • Supply, recall or access changes

Sources

The original report was published by STAT. WorldPing does not claim that reporting — this page summarises and contextualises it.

Read the full report at STAT

Related WorldPing coverage

Study challenges estimates used to guide Atlantic menhaden fishingWorldPing
Phys.org

Study challenges estimates used to guide Atlantic menhaden fishing

Atlantic menhaden (Brevoortia tyrannus), which supports a major commercial fishery along the U.S. East Coast and serves as essential prey for fish, seabirds and marine mammals, may be less able to sustain fishing pressure than some assessments suggest.

Brief by WorldPing · Original reporting by Phys.org